At a glance
ClinicalIndex Comparison RecordN/ACompleted· 192 enrolled
Drug / intervention
TRIIUMPH Interventionother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Trial of Integrated Smoking Cessation, Exercise and Weight Management in Serious Mental Illness: TRIUMPH
In Brief
A clinical study evaluating TRIIUMPH Intervention for Mental Illness. Completed, enrolled 192 participants across 1 site.
Detailed Summary
This study will determine whether an 18-month practical tobacco smoking cessation program integrating weight management counseling and exercise will be superior to treatment as usual in achieving prolonged smoking abstinence in persons with serious mental illness.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMental Illness
CountriesUnited States
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedApr 2015
Enrollment StartJul 2016
Primary CompletionMar 2020
TodayJul 2026
First PostedApr 22, 2015
Enrollment StartJul 7, 2016
Primary CompletionMar 1, 2020
TodayJul 2, 2026
Enrollment to primary: 3.6 yearsPosted 11.2 years ago
Interventions
TRIIUMPH Interventionother
Group and individual smoking cessation and weight management counseling, pharmacotherapy with varenicline or bupropion and nicotine replacement therapy, group exercise, and text messaging support